High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1897-4287
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population ; volume:16 ; number:1 ; day:5 ; month:6 ; year:2018 ; pages:1-7 ; date:12.2018
Hereditary cancer in clinical practice ; 16, Heft 1 (5.6.2018), 1-7, 12.2018
- Classification
-
Medizin, Gesundheit
- Creator
-
Maksimenko, J.
- Contributor
-
Irmejs, A.
Trofimovičs, G.
Bērziņa, D.
Skuja, E.
Purkalne, G.
Miklaševičs, E.
Gardovskis, J.
SpringerLink (Online service)
- DOI
-
10.1186/s13053-018-0094-0
- URN
-
urn:nbn:de:101:1-2018081121403372564122
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Maksimenko, J.
- Irmejs, A.
- Trofimovičs, G.
- Bērziņa, D.
- Skuja, E.
- Purkalne, G.
- Miklaševičs, E.
- Gardovskis, J.
- SpringerLink (Online service)
Other Objects (12)
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing
The Icelandic founder mutation BRCA2 999del5: analysis of expression
Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland
Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank
BRCA1 4153delA founder mutation in Russian ovarian cancer patients
Concurrent germline BRCA1, BRCA2, and CHEK2 pathogenic variants in hereditary breast cancer: a case series
Chapter V. Founder
A Case of Triple-Negative Breast Cancer with Germline Pathogenic Variants in Both BRCA1 and BRCA2
BRCA1 and BRCA2 germline mutation analysis in the Indonesian population
The germline mutational landscape of BRCA1 and BRCA2 in Brazil
COVID-19 vaccination uptake and safety profile among germline BRCA1 and BRCA2 pathogenic variant carriers in Singapore
Islam and its founder
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing
The Icelandic founder mutation BRCA2 999del5: analysis of expression
Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland
Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank
BRCA1 4153delA founder mutation in Russian ovarian cancer patients
Concurrent germline BRCA1, BRCA2, and CHEK2 pathogenic variants in hereditary breast cancer: a case series
Chapter V. Founder
A Case of Triple-Negative Breast Cancer with Germline Pathogenic Variants in Both BRCA1 and BRCA2
BRCA1 and BRCA2 germline mutation analysis in the Indonesian population
The germline mutational landscape of BRCA1 and BRCA2 in Brazil
COVID-19 vaccination uptake and safety profile among germline BRCA1 and BRCA2 pathogenic variant carriers in Singapore
Islam and its founder
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing
The Icelandic founder mutation BRCA2 999del5: analysis of expression
Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East Poland
Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank
BRCA1 4153delA founder mutation in Russian ovarian cancer patients
Concurrent germline BRCA1, BRCA2, and CHEK2 pathogenic variants in hereditary breast cancer: a case series
Chapter V. Founder
A Case of Triple-Negative Breast Cancer with Germline Pathogenic Variants in Both BRCA1 and BRCA2
BRCA1 and BRCA2 germline mutation analysis in the Indonesian population
The germline mutational landscape of BRCA1 and BRCA2 in Brazil
COVID-19 vaccination uptake and safety profile among germline BRCA1 and BRCA2 pathogenic variant carriers in Singapore